Smoking Treatment of Prisoners: Project "STOP"

National Institute on Drug Abuse (NIDA)1 site in 1 country250 target enrollmentJune 2005

ConditionsTobacco Use Cessation Tobacco Use Disorder

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Tobacco Use Cessation
Sponsor: National Institute on Drug Abuse (NIDA)
Enrollment: 250
Locations: 1
Primary Endpoint: smoking cessation
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Detailed Description

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Registry

clinicaltrials.gov

Start Date

June 2005

End Date

September 2007

Last Updated

9 years ago

Study Type

Interventional

Sex

Female

Investigators

Sponsor

National Institute on Drug Abuse (NIDA)

Eligibility Criteria

Inclusion Criteria

•current smoker and (2) seeking group treatment to quit smoking.

Exclusion Criteria

•(1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.